Logo-apb
Adv Pharm Bull. 2023;13(1): 24-35.
doi: 10.34172/apb.2023.003
PMID: 36721812
PMCID: PMC9871280
  Abstract View: 826
  PDF Download: 348
  Full Text View: 65

Review Article

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy

Somayyeh Ghareghomi 1 ORCID logo, Vahideh Atabaki 2 ORCID logo, Naseh Abdollahzadeh 3, Shahin Ahmadian 1* ORCID logo, Salar Hafez Ghoran 4,5* ORCID logo

1 Department of Biochemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
2 Department of Pharmacognosy and Pharmaceutical Biotechnology, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
3 Neurophysiology Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.
4 Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5 Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
*Corresponding Authors: *Corresponding Authors: Shahin Ahmadian, Email: , Email: Sh.ahmadian@ut.ac.ir; *Corresponding Authors: Salar Hafez Ghoran, Email: , Email: S_Hafezghoran@yahoo.com

Abstract

One of the central signaling pathways with a regulatory effect on cell proliferation and survival is Akt/mTOR. In many human cancer types, for instance, lung cancer, the overexpression of Akt/mTOR has been reported. For this reason, either targeting cancer cells by synthetic or natural products affecting the Akt/mTOR pathway down-regulation is a useful strategy in cancer therapy. Direct inhibition of the signaling pathway or modulation of each related molecule could have significant feedback on the growth and proliferation of cancer cells. A variety of secondary metabolites has been identified to directly inhibit the AKT/mTOR signaling, which is important in the field of drug discovery. Naturally occurring nitrogenous and phenolic compounds can emerge as two pivotal classes of natural products possessing anticancer abilities. Herein, we have summarized the alkaloids and flavonoids for lung cancer treatment together with all the possible mechanisms of action relying on the Akt/mTOR pathway down-regulation. This review suggested that in search of new drugs, phytochemicals could be considered as promising scaffolds to be developed into efficient drugs for the treatment of cancer. In this review, the terms “Akt/mTOR”, “Alkaloid”, “flavonoid”, and “lung cancer” were searched without any limitation in search criteria in Scopus, PubMed, Web of Science, and Google scholar engines.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 827

Your browser does not support the canvas element.


PDF Download: 348

Your browser does not support the canvas element.


Full Text View: 65

Your browser does not support the canvas element.

Submitted: 04 Jun 2021
Revision: 27 Jul 2021
Accepted: 28 Sep 2021
ePublished: 09 Oct 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)